Accelerated Approval Requests Based On Low Efficacy Frustrate FDA

FDA appears to be increasingly frustrated with sponsors who seek accelerated approval based upon the lowest possible efficacy standard

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet